Coagulation Factor VII Activity (Factor VII)
Vitamin K-dependent serine protease with the shortest biological half-life (~4 to 6 hours) of all circulating coagulation factors.
Standard vs. Optimal Reference Ranges% Activity
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
65 - 140%
General reference distribution across unselected commercial populations.
75 - 130%
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Binds exposed subendothelial tissue factor (TF) at sites of vascular injury to form the extrinsic tenase complex (TF-VIIa), initiating the clotting cascade.
Differential Diagnosis
Elevated Levels (Factor VII High)
- •Early acute phase elevation
- •High triglyceride / hyperlipidemia state
Low Levels (Factor VII Low)
- •Acute fulminant hepatic failure (early precipitous decline)
- •Warfarin anticoagulation (cleared first)
- •Vitamin K deficiency
- •Congenital Factor VII deficiency
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for Factor VII
- Targeted organ system imaging or functional dynamic testing related to extrinsic pathway trigger
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Coagulation Factor VII Activity - The New England Journal of Medicine (2021). PMID: 34090124
- [2]Factor VII Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Coagulation Factor VII Activity (Factor VII) into overall healthspan optimization.